# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001802768-23-000007
Filing Date
2023-02-15
Accepted
2023-02-15 09:03:27
Documents
89
Period of Report
2022-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | rprx-20221231.htm iXBRL | 10-K | 3556758
2 | EX-4.2 | rprx-20221231ex42.htm | EX-4.2 | 40856
3 | EX-21.1 | rprx-20221231ex211.htm | EX-21.1 | 7059
4 | EX-23.1 | rprx-20221231ex231.htm | EX-23.1 | 3880
5 | EX-31.1 | rprx-20221231ex311.htm | EX-31.1 | 9322
6 | EX-31.2 | rprx-20221231ex312.htm | EX-31.2 | 9387
7 | EX-32 | rprx-20221231ex32.htm | EX-32 | 5204
13 |  | rprx-20221231_g1.jpg | GRAPHIC | 68631
14 |  | rprx-20221231_g2.jpg | GRAPHIC | 159106
15 |  | rprx-20221231_g3.jpg | GRAPHIC | 166802
16 |  | rprx-20221231_g4.jpg | GRAPHIC | 135800
| Complete submission text file | 0001802768-23-000007.txt |  | 14688615

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rprx-20221231.xsd | EX-101.SCH | 83705
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | rprx-20221231_cal.xml | EX-101.CAL | 101739
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | rprx-20221231_def.xml | EX-101.DEF | 483788
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rprx-20221231_lab.xml | EX-101.LAB | 889852
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rprx-20221231_pre.xml | EX-101.PRE | 607733
83 | EXTRACTED XBRL INSTANCE DOCUMENT | rprx-20221231_htm.xml | XML | 2498176

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39329 | Film No.: 23633803
SIC: 2834 Pharmaceutical Preparations